Letters
Opening up data at the EMA
Proactive transparency?
BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d3840 (Published 20 June 2011) Cite this as: BMJ 2011;342:d3840
- A Chailleu, member, management board1,
- P Foucras, president1
- 1Formindep, F 59100 Roubaix, France
- a.chailleu{at}formindep.org
Formindep (www.formindep.org) is an independent self funded association of health professionals and citizens that advocates for transparency in medical information and education and freedom from interests other than those of patients. Our experience of the European Medicines Agency’s (EMA) implementation of its transparency policy agrees with Gøtzsche and Jørgensen’s findings.1
Directive 1049/2001/EC,2 which …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.